1. Home
  2. RVYL vs NTBL Comparison

RVYL vs NTBL Comparison

Compare RVYL & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVYL
  • NTBL
  • Stock Information
  • Founded
  • RVYL 2007
  • NTBL 2000
  • Country
  • RVYL United States
  • NTBL United States
  • Employees
  • RVYL N/A
  • NTBL N/A
  • Industry
  • RVYL Professional Services
  • NTBL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVYL Consumer Discretionary
  • NTBL Health Care
  • Exchange
  • RVYL Nasdaq
  • NTBL Nasdaq
  • Market Cap
  • RVYL 13.7M
  • NTBL 6.6M
  • IPO Year
  • RVYL N/A
  • NTBL N/A
  • Fundamental
  • Price
  • RVYL $1.76
  • NTBL $0.70
  • Analyst Decision
  • RVYL Hold
  • NTBL Strong Buy
  • Analyst Count
  • RVYL 1
  • NTBL 2
  • Target Price
  • RVYL N/A
  • NTBL $7.00
  • AVG Volume (30 Days)
  • RVYL 42.3K
  • NTBL 78.5K
  • Earning Date
  • RVYL 08-12-2024
  • NTBL 08-15-2024
  • Dividend Yield
  • RVYL N/A
  • NTBL N/A
  • EPS Growth
  • RVYL N/A
  • NTBL N/A
  • EPS
  • RVYL N/A
  • NTBL N/A
  • Revenue
  • RVYL $71,352,000.00
  • NTBL $311,000.00
  • Revenue This Year
  • RVYL $31.47
  • NTBL N/A
  • Revenue Next Year
  • RVYL N/A
  • NTBL N/A
  • P/E Ratio
  • RVYL N/A
  • NTBL N/A
  • Revenue Growth
  • RVYL 78.42
  • NTBL N/A
  • 52 Week Low
  • RVYL $1.12
  • NTBL $0.51
  • 52 Week High
  • RVYL $17.50
  • NTBL $10.85
  • Technical
  • Relative Strength Index (RSI)
  • RVYL 50.51
  • NTBL 49.21
  • Support Level
  • RVYL $1.66
  • NTBL $0.67
  • Resistance Level
  • RVYL $2.25
  • NTBL $0.75
  • Average True Range (ATR)
  • RVYL 0.22
  • NTBL 0.06
  • MACD
  • RVYL -0.02
  • NTBL 0.02
  • Stochastic Oscillator
  • RVYL 31.18
  • NTBL 64.36

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About NTBL Notable Labs Ltd.

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.

Share on Social Networks: